Tailored Inhaled Development Services
Product Description
VECTURA GROUP PLC
-
GB -
2020On CPHI since
-
250 - 499Employees
Company types
Categories
VECTURA GROUP PLC
-
GB
-
2020On CPHI since
-
250 - 499Employees
Company types
More Products from VECTURA GROUP PLC (7)
-
Product Inhaled Formulation Development
With expertise in powder and liquid formulations for small molecules and biologics, as well as a broad portfolio of proprietary device and formulation technologies, we can help you overcome the challenges of inhaled formulation development.
Dry Powder Formulation
Advanced po... -
Product Analytical Services - Inhaled Products
With extensive, state-of-the-art analytical testing facilities and equipment, our expert teams are able to develop and validate the methodologies required to characterise inhaled delivery platforms, especially DPI, pMDI and nebulised products.
To ensure seamless support for your development... -
Product Process Development & Inhaled Product Manufacturing
In addition to extensive development manufacturing facilities, Vectura has GMP manufacturing facilities for dry powder inhalers, pMDI and nebuliser medical devices as well as further capability to handle biological molecules.
Our GMP manufacturing facilities and equipment are relevant-to-comme... -
Product Medical & Regulatory Services - Inhaled Products
Our formulation, device and development services are supported by our medical, regulatory, device vigilance and pharmacovigilance teams to safeguard your programme and ensure the smoothest path to product approval.
Our in-house team can support with:
Global regulatory development strategy... -
Product Dry Powder Inhalers (DPI)
Our dry powder inhalers are derived from the commercially-validated AirFluSal® Gyrohaler® platform, but with a range of user interfaces and payload volumes, giving you confidence of performance and a proven regulatory track record.
With options for proprietary unit- and multi-unit dose platforms... -
Product SMART Nebulisers
Our state-of-the-art breath-actuated nebulisers with guided inhalation have been developed to improve lung delivery for inhaled drugs, with the aim of achieving better clinical outcomes and/or shortened treatment times.
FOX® nebuliser: handheld system that delivers high... -
Product Inhalation Device Platforms
Access the delivery technology best suited to the needs of your development programme, including unit-dose and multi-unit dose DPIs, pMDIs and smart nebulisers, suitable for home or hospital applications.
Dry Powder Inhalers:
Options include proprietary unit- and multi-unit dose platforms, as w...
VECTURA GROUP PLC resources (14)
-
News Discover the CPHI North America Learning Labs: Part Two
Explore the series of Learning Labs at CPHI North America in which thought leaders at our exhibitors showcase their extensive knowledge on all areas of the pharma supply chain, offering industry insights across drug manufacturing, outsourcing, pharma ingredients, drug delivery and packaging. -
Video Take a Breath: Selecting a Device for Inhaled Product Development
This session was originally broadcast as part of the CPHI Worldwide 2021 digital content programme. The future commercial success of any new inhaled medicine relies largely on the correct combination of formulation and device technology chosen for its delivery. This presentation benefits any drug developer considering an inhaled programme and aims to answer the following questions: How are development targets and success criteria set for inhaled products? What are the key factors influencing inhaled delivery platform selection? How can phase-appropriate device selection accelerate an inhaled development programme? -
News Vectura to provide preclinical support for Incannex's inhaled brain injury treatment
IHL-216A may make sports safer and reduce the morbidity and mortality rates of people suffering serious head traumas -
Brochure Vectura Inhaled Services and Capabilities
Vectura inhaled formulation, device and development services -
News Inhalation specialist Vectura invests to expand manufacturing capabilities
The enhancements will include installing the lever-operated multi-dose inhaler device used in Hikma’s generic Advair product, which the FDA recently approved -
News Vectura expands capabilities to develop highly potent inhaled drugs
The expansion will enable the CDMO to widen the nature of inhaled drug development projects it can undertake for customers -
Whitepaper Article - Accelerating Inhaled Drug Development
Strategies to accelerate inhaled drug development including technology platform selection. -
Whitepaper Article - From Feasibility to Final Product
Exploring the many factors which contribute to the success of pMDI, DPI and nebuliser development programmes -
Video Take a Breath: Selecting a Device for Inhaled Product Development
The future commercial success of any new inhaled medicine relies in a large part on the correct combination of formulation and device technology chosen for its delivery. This presentation will benefit any drug developer considering an inhaled programme and aims to answer the following questions: How are development targets and success criteria set for inhaled products? What are the key factors influencing inhaled delivery platform selection? How can phase-appropriate device selection accelerate an inhaled development programme? This session was originally broadcast live as part of CPHI North America 2021 -
Video Fast-to-Clinic Approaches (Free Webcast)
Download this free webcast where Dr Sandy Munro, SVP Pharmaceutical Development, discusses strategies to progress inhaled products quickly to clinical stages of development. -
Brochure From Feasibility to Final Product
Interested in the critical success factors for an inhaled development programme? Download this article which discusses inhaled delivery platform selection and strategies to accelerate development timelines and reduce risk. -
Brochure Breathing New Life Into Existing Drugs
This article discusses how delivery technology can help customers develop existing drugs for inhaled use, as well as highlighting the key challenges and opportunities faced during inhaled product development. -
Brochure Choose a partner to help you succeed
Download a summary of Vectura's services and capabilities
Frequently Viewed Together
-
Product Core Technologies and Services
• API / GMP Manufacturing • Rapid Process Development, Flawless Upscaling, and Economy of Scale-Production • Simulated-Moving Bed (SMB) Chromatography • Heterocyclic, Hazardous and Malodorous Chemistries • Organometallic and Cryogenic Chemistry • Transition-Metal Catalysis • High-Pressur...
-
Product Drug Product
At Recipharm, we offer drug product development services for all common dosage forms. Our team can manage the complexity of your project, helping you find the best solution whether you are looking for development support to take your product to first-in-human (FIH) studies or to advance your product to mar...
-
Product Custom Protein Synthesis
We provide a Custom Protein Synthesis Service, using a chemical method that synthesises proteins amino acid by amino acid and making modifications on an atomic-scale. We work closely with our partners in designing, customising and optimising the proteins that is synthesized in an automa...
-
Product VetaFilmTM - Veterinary Oral Film Technology
VetaFilm™ is our proprietary veterinary oral film technology that provides significant market opportunities to improve drug delivery for companion animals. VetaFilm™ research and development services and veterinary oral films provide: • Dose placed directly on oral mucosa or on their f...
-
Product The Luer Vial by GEMÜ
The Luer Vial by GEMÜ combines optimal shelf life with standardised containers that can be filled aseptically. Safety and user-friendliness are enhanced by a customised applicator that allows precise drug delivery by single-handed operation.
The Luer Vial by GEMÜ was developed as a modular pa...
-
Product Springs and Stamped & Bent Parts for Pen Injectors
Tailor-made solutions in springs, stamping & bending and assemblies for enhanced pen injector performance and patient safety. Pen injectors require patients to manually attach a pen needle, unlike autoinjectors that come with a needle attached. This handheld device enables patients to administer m...
-
.jpg)
Product RoSS® Shell: Protection of single-use bags
Protect your single-use bioprocess containers: RoSS® Shells - abbreviated for Robust Storage and Shipping - reduce product loss towards 0%. Compatible with all available sizes and types of single-use bags, RoSS enables standardized and scalable end-to-end process solutions for fluid management and col...
-
Product Gemcitabine
GEMCITABINE 200 & 1000 & 2000 mg parenteral solution – Pancreatic and Breast cancer. Authorized: EU-CTD Dossier
-
Product Nanoparticles
Particle Engineering Technologies
We specialize in particle engineering technologies to address oral bioavailability, lung delivery, modified release and taste masking. In each technology we can support you from proof of concept to commercial manufacturing.
Nanoparticles
At Hovione we ...
-
Product Molly® 2.25 Modular Platform Autoinjector
Molly® 2.25 is a large-volume variant of the Molly autoinjector to accommodate larger-volume biologics. Featuring the same easy-to-use, 2-step operation, it inherited the modular platform development model to support high-volume manufacturing, faster development, and flexible design for unique branding nee...
-
Product CordenPharma Derivatized Phospholipids - DPPC & More
CordenPharma’s expert lipid manufacturers have mastered the chemical total synthesis of complex phospholipid derivatives from multi-gram to multi-kilogram scale and are renowned for their contract lipid and phospholipid molecule manufacturing expertise. Our large-scale proprietary cGMP manufacturing proces...
-
Product Biologic drug substance CDMO services
From pre-clinical development to commercial supply, Patheon by Thermo Fisher Scientific is an industry leader in the development and manufacture of mammalian cell culture drug substances. Patheon offers biotech and pharmaceutical companies the ability to pursue opportunities around the globe with a fully i...
-
Product Oradel
The proprietary Oradel platform is a line of oral delivery coating techniques that can be used individually or together to meet any custom delivery requirements. Our Wurster coating capabilities allow us to add numerous coating layers to a core. These layers could be a simple coating formulation or could c...
-comp245299.svg)
Recently Visited
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance